Autolus Therapeutics Plc (AUTL)
1.47
+0.05
(+3.52%)
USD |
NASDAQ |
Jan 21, 16:00
1.47
0.00 (0.00%)
After-Hours: 06:17
Autolus Therapeutics Cash from Investing (Quarterly): 35.49M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
| Mereo BioPharma Group Plc | 0.3027M |
| Bicycle Therapeutics Plc | -0.6709M |
| DBV Technologies SA | -0.2404M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -67.40M |
| Cash from Financing (Quarterly) | -1.777M |
| Free Cash Flow | -306.93M |
| Free Cash Flow Per Share (Quarterly) | -0.3001 |
| Free Cash Flow to Equity (Quarterly) | -89.88M |
| Free Cash Flow to Firm (Quarterly) | -69.34M |
| Free Cash Flow Yield | -78.46% |